Unlike prior reports of fasting beyond 21 days in non-obese individuals [11, 12], this case demonstrates substantial weight loss (125 pounds) accompanied by improvements in depression, anemia, hypoxia/hypercapnia, functional status, and left ventricular (LV) mass
Instead, pick light, simple options with neutral flavors like a turkey sandwich or soup
FDA prescribing information for some GLP-1 receptor agonists (particularly those approved for weight management) includes recommendations to monitor heart rate at regular intervals and consider discontinuation for sustained increases in resting heart rate
[JNM] 66
Consulting a healthcare provider is crucial to determine suitability
licensed UK options include orlistat, semaglutide (Wegovy, TA875), and liraglutide (Saxenda, TA664), all with established safety profiles